# Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults

> **NCT07144527** · NA · RECRUITING · sponsor: **Scott Silveira** · enrollment: 40 (estimated)

## Conditions studied

- Aging
- Frailty
- Exercise Tolerance
- Healthy Male and Female Subjects

## Interventions

- **DIETARY_SUPPLEMENT:** NMN, betaine, low-dose hydrogen peroxide (EGA)
- **DIETARY_SUPPLEMENT:** Nicotinamide Mononucleotide (NMN)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07144527
- **Lead sponsor:** Scott Silveira
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-21
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144527, "Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07144527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*